Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA.
J Mammary Gland Biol Neoplasia. 2011 Sep;16(3):189-203. doi: 10.1007/s10911-011-9224-2. Epub 2011 Jul 26.
The innate immune system ensures effective protection against foreign pathogens and plays important roles in tissue remodeling. There are many types of innate immune cells, including monocytes, macrophages, dendritic cells, and granulocytes. Interestingly, these cells accumulate in most solid tumors, including those of the breast. There, they play a tumor-promoting role through secretion of growth and angiogenic factors, as well as immunosuppressive molecules. This is in strong contrast to the tumor-suppressing effects that innate immune cells exert in vitro upon proper activation. Therapeutic approaches have been developed with the aim of achieving similar suppressive activities in vivo. However, multiple factors in the tumor microenvironment, many of which are immunosuppressive, represent a major obstacle to effective treatment. Here, we discuss the potential of combating breast cancer through activation of the innate immune system, including possible strategies to enhance the success of immunotherapy.
固有免疫系统可有效抵御外来病原体,并在组织重塑中发挥重要作用。固有免疫细胞包括单核细胞、巨噬细胞、树突状细胞和粒细胞等多种类型。有趣的是,这些细胞在大多数实体瘤中聚集,包括乳腺癌。在那里,它们通过分泌生长和血管生成因子以及免疫抑制分子发挥促肿瘤作用。这与固有免疫细胞在适当激活时在体外发挥的肿瘤抑制作用形成鲜明对比。已经开发出治疗方法,旨在在体内实现类似的抑制活性。然而,肿瘤微环境中的多种因素,其中许多具有免疫抑制作用,是有效治疗的主要障碍。在这里,我们讨论了通过激活固有免疫系统来对抗乳腺癌的潜力,包括增强免疫疗法成功的可能策略。